STAT3 and intrahepatic cholangiocarcinoma: The qRT-PCR results further confirmed and justified our findings from ICC, immunofluorescence, and Western blot, providing strong evidence that BY4003 and BY4008 effectively suppressed STAT3 activation and inhibited GBM cell growth and proliferation.